AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Briteova 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Medgrow Health Care

Salt Composition

Letrozole (2.5mg)

Overview Briteova 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Briteova 2.5mg tablets. This medication can be a standalone treatment or used alongside other therapies like surgery or radiotherapy. In advanced cases, it helps curb the cancer's spread. Briteova 2.5mg tablets can be taken with or without food, always following your doctor's prescribed dosage and duration for optimal results. Dosage varies depending on the treatment goal, determined by your physician to manage your symptoms effectively. Continue taking the medication as directed. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to starting treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Disclose all other medications you're using, as interactions can affect Briteova's efficacy. If pregnant or breastfeeding, consult your doctor. Blood tests to monitor vitamin D levels and bone density may be conducted before and during treatment.

Primary Ingredients of Briteova 2.5 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Briteova 2.5 Tablet

Managing breast cancer

Major Benefits of Briteova 2.5 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Briteova 2.5 Tablet can be administered with or without food, although consistent timing is recommended.

Common Side effects of Briteova 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Briteova 2.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Briteova 2.5 Tablet. Swallow the tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day.

How Briteova 2.5 Tablet works:

Estrogen production is reduced by Briteova 2.5 mg tablets, an aromatase inhibitor. This lowers estrogen levels, potentially inhibiting or slowing the growth of estrogen-receptor-positive breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Briteova 2.5 Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Using Briteova 2.5 Tablet during pregnancy poses a considerable risk. Pregnant women should consult their physician; research in animals and pregnant women indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Briteova 2.5 Tablet are incompatible; the medication poses a potential risk of infant harm due to its toxic effects.

DrivingDrivingUNSAFE

Taking Briteova 2.5 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, Briteova 2.5 Tablet is considered safe and does not require a dosage alteration. Data on its use in patients experiencing end-stage renal disease, however, is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Briteova 2.5 mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Briteova 2.5 Tablet :

Should you forget a Briteova 2.5 Tablet dose, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Briteova 2.5 Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Briteova 2.5 Tablet

Briteova 2.5 Tablets are an aromatase inhibitor, typically prescribed for postmenopausal women with breast cancer, including those who have undergone surgery or chemotherapy.
Briteova 2.5 Tablet is an anti-estrogen medication. It works by inhibiting aromatase, the enzyme that produces estrogen, thereby lowering estrogen levels. This is significant because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue taking Briteova 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Briteova 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Briteova 2.5 Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Briteova 2.5 Tablet concurrently, but monitor your blood pressure closely as Briteova 2.5 Tablet can elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Briteova 2.5 Tablet may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Briteova 2.5 Tablet, linked to decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment, subsiding within months afterward. If bothersome, consult your doctor for management options.
While rare, serious side effects of Briteova 2.5 Tablet may include stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Briteova 2.5 Tablet can reduce bone density (osteoporosis) due to lowered estrogen. Your doctor may monitor your bone density with tests before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Briteova 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Briteova 2.5 Tablet
157